Winifred L. Swan, SVP and General Counsel at NxStage Medical, Inc. (NXTM), sold 6,260 shares at $14.95 ($103K) on 2016-04-14, disclosed to the SEC on 2016-04-15.
Scheduled sale ($103k) by SVP and General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.04 | 1,880 | $36K | 34.9% |
| 2 | $15.69 | 1,880 | $29K | 28.7% |
| 3 | $14.95 | 2,500 | $37K | 36.4% |
| Total | $16.40 avg | 6,260 | $103K | 100% |
| Filing → |
| NXTM | SELL | 2017-12-21 | $89K | — | Filing → |
| NXTM | SELL | 2017-11-15 | $90K | — | Filing → |
| NXTM | SELL | 2017-10-23 | $96K | — | Filing → |